WallStreetZenWallStreetZen

NASDAQ: ROIV
Roivant Sciences Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Roivant Sciences earnings were -$809.2M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest ROIV earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$265.9M, up 134.2% from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, ROIV reported annual earnings of -$172.0M, with -104% growth.

ROIV earnings history

Current Revenue
$13.3M
Current Earnings
-$809.2M
Current Profit Margin
-6,079.9%

ROIV Return on Equity

Current Company
-18.3%
Current Industry
31.2%
Current Market
35.4%
ROIV's Return on Equity (-18.3%)... subscribe to Premium to read more.
High Return on Equity Performance

ROIV Return on Assets

Current Company
-15.6%
Current Industry
10.8%
ROIV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ROIV announces earnings.

ROIV Return on Capital Employed

Current Company
-14.29%
Current Industry
21.3%
ROIV has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ROIV vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ROIV-$712.42M-$809.24MN/A-$1.17
RVMD-$934.16M-$960.98MN/A-$5.18
GMAB$1.54B$963.00M+8.69%$1.55
INCY$1.76B$1.29B+11.26%$6.59
UTHR$1.77B$1.27B+21.79%$28.48
View Top Biotech Stocks

Roivant Sciences Earnings Reports & History FAQ

What were Roivant Sciences's earnings last quarter?

On ROIV's earnings call on Invalid Date, Roivant Sciences (NASDAQ: ROIV) reported Q4 2025 earnings per share (EPS) of -$0.38, up 265.22% year over year. Total ROIV earnings for the quarter were -$265.89 million. In the same quarter last year, Roivant Sciences's earnings per share (EPS) was $0.23.

If you're new to stock investing, here's how to buy Roivant Sciences stock.

Is Roivant Sciences profitable or losing money?

As of the last Roivant Sciences earnings report, Roivant Sciences is currently losing money. Roivant Sciences's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$809.24 million, a 593.91% increase year over year.

What was ROIV's earnings growth in the past year?

As of Roivant Sciences's earnings date in Invalid Date, Roivant Sciences's earnings has grown year over year. ROIV earnings in the past year totalled -$809.24 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.